Judge Refuses GlaxoSmithKline Motion for New Paxil Suicide Trial

Chicago, Illinois -- A federal judge has entered judgment against GlaxoSmithKline (“GSK”) affirming the April 20, 2017 jury verdict in favor of Wendy Dolin who alleged her husband’s 2010 suicide was the result of side effects he suffered while taking generic Paxil (paroxetine). Following the jury’s $3,000,000 verdict in Dolin’s [...]

By | September 14th, 2017|Blog, Michael L. Baum, Paxil News, Pharma News, Press Releases, R. Brent Wisner|

UK Launches Inquiry into Contaminated Blood Scandal

United Kingdom Prime Minister Theresa May announced yesterday that her nation’s government will conduct an inquiry into the contaminated blood scandal that killed an estimated 2,400 people in the country and left countless others terminally ill. The scandal dates back to the late 1970s and early 1980s when hemophilia patients [...]

By | July 13th, 2017|Blog, Michael L. Baum, Top Stories|

$3M Jury Verdict Against GSK in Landmark Paxil Suicide Case

April 20, 2017, Chicago, Illinois - - A federal jury has sided with the widow of a deceased Chicago attorney in her generic Paxil suicide lawsuit against GlaxoSmithKline (GSK), ordering the pharmaceutical giant to pay $3 million. The jury verdict resolves allegations in the trial of Dolin v. Smithkline Beecham [...]

Baum Hedlund and Robert F. Kennedy, Jr. Hold Press Conference to Support California in Fight Against Monsanto

Fresno, California – Jan. 27, 2017 - - Robert F. Kennedy, Jr., Michael Baum of the law firm Baum, Hedlund, Aristei & Goldman and a number of their clients spoke at a press conference outside of the B.F. Sisk Courthouse in Fresno on Friday to support the State of California [...]

By | January 27th, 2017|Blog, Michael L. Baum, Monsanto Roundup News, Press Releases|

Michael L. Baum on Executive Committee for Monsanto Roundup MDL

Los Angeles, California – Dec. 22, 2016 - - Baum, Hedlund, Aristei & Goldman managing partner, Michael L. Baum, has been appointed to serve on the Executive Committee for the recently consolidated federal Monsanto Roundup lawsuits. U.S. District Judge Vince Chhabria, who is presiding over the Roundup multidistrict litigation (MDL), [...]

By | December 22nd, 2016|Blog, Michael L. Baum, Monsanto Roundup News, Press Releases|

Record Number of Attorneys from Baum Hedlund Aristei and Goldman Recognized in Southern California Super Lawyers

Los Angeles, February 2, 2016 - - Attorneys across Southern California have given high votes to eight lawyers at Baum Hedlund Aristei & Goldman, listing them among other outstanding attorneys in the current issue of Southern California Super Lawyers®. Super Lawyers® uses a patented selection process to create a trusted list [...]

Best Lawyers in America Awards

Baum Hedlund is Listed in The Best Lawyers in America® 2016 Our lawyers listed in The Best Lawyers in America®2016  A. Ilyas Akbari, Product Liability Litigation – Plaintiffs | 2016 J. Clark Aristei, Mass Tort Litigation / Class Actions – Plaintiffs | 2016 Michael L. Baum, Personal Injury Litigation – [...]

Attorney Tells All: How the U.S. Courts Shield Big Pharma from Liability

It’s not easy to sue Big Pharma.  But, legal firm Baum Hedlund has been doing it for years.  Unfortunately, as pharmaceutical deceit and side-effects grow, it’s getting exponentially more difficult.  After all, using prescription drugs as prescribed is the top killer in the USA. I reached out to attorney Michael Baum to get a [...]

By | November 23rd, 2015|Blog, Michael L. Baum, Pharma News, Press Releases|

Documentary Filmmakers Interview Prominent Attorney about the Dangers of Antidepressants

Mr. Baum is one of several experts the filmmakers chose to provide commentary on the risks antidepressants pose, especially to women of childbearing age. As an attorney, he has spent decades working on behalf of clients who have suffered adverse reactions and serious side effects from antidepressants. He and his law firm [...]

By | November 23rd, 2015|Michael L. Baum|

Misleading Paxil Study Exposed in New BMJ Study

Study 329, a Poster Child of tainted scientific research, has finally gotten its comeuppance. Study 329 was published in 2001 by over a dozen well-credentialed academics whose names lent credence to the study’s conclusions, but unbeknownst to the medical community and public, the study was ghostwritten by a PR company hired [...]

By | September 18th, 2015|Michael L. Baum, Paxil News, Pharma News|